Pluristem (PSTI) - Cash Flow Conversion Efficiency

Latest as of March 2022: -0.235x

Based on the latest financial reports, Pluristem (PSTI) has a cash flow conversion efficiency ratio of -0.235x as of March 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-9.42 Million ≈ $-25.26K USD) by net assets (ILA40.14 Million ≈ $107.62K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Pluristem stock valuation for the company's overall valuation and market capitalisation.

Pluristem - Cash Flow Conversion Efficiency Trend (2014–2021)

This chart illustrates how Pluristem's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Pluristem Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pluristem ranked by their cash flow conversion efficiency. See Pluristem cash debt coverage ratio to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
FiEE, Inc. NASDAQ:FIEE	0.002x
Shanghai Material Trading Co Ltd B SHG:900927	-0.212x
Tera Software Limited NSE:TERASOFT	-0.055x
Etiler İnci Bufe Gida Sanayi ve Dis Ticaret AS IS:ETILR	-0.381x
Slj Global Tbk JK:SULI	-0.018x
NovaBay Pharmaceuticals Inc NYSE MKT:NBY	0.100x
Dental Corporation Public Company Limited BK:D	0.049x
Brixton Metals Corporation V:BBB	-0.147x

Annual Cash Flow Conversion Efficiency for Pluristem (2014–2021)

The table below shows the annual cash flow conversion efficiency of Pluristem from 2014 to 2021. View PSTI stock price and chart for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2021-06-30	ILA57.15 Million ≈ $153.22K	ILA-30.91 Million ≈ $-82.87K	-0.541x	-15.07%
2020-06-30	ILA56.10 Million ≈ $150.40K	ILA-26.37 Million ≈ $-70.69K	-0.470x	+65.18%
2019-06-30	ILA21.82 Million ≈ $58.50K	ILA-29.45 Million ≈ $-78.96K	-1.350x	-79.97%
2018-06-30	ILA28.51 Million ≈ $76.43K	ILA-21.38 Million ≈ $-57.32K	-0.750x	-4.98%
2017-06-30	ILA30.25 Million ≈ $81.10K	ILA-21.61 Million ≈ $-57.94K	-0.714x	-47.17%
2016-06-30	ILA38.16 Million ≈ $102.29K	ILA-18.52 Million ≈ $-49.66K	-0.485x	-36.98%
2015-06-30	ILA58.14 Million ≈ $155.88K	ILA-20.61 Million ≈ $-55.24K	-0.354x	-15.14%
2014-06-30	ILA62.12 Million ≈ $166.55K	ILA-19.12 Million ≈ $-51.26K	-0.308x	--

About Pluristem

TA:PSTI Israel Biotechnology & Medical Research

Market Cap

$32.23 Million

ILA12.02 Billion ILA

Market Cap Rank

#23603 Global

#329 in Israel

Share Price

ILA371.60

Change (1 day)

+0.16%

52-Week Range

ILA371.00 - ILA1598.00

All Time High

ILA72010.00